By Sahil Pandey Feb 9 (Reuters) - Medical device maker Becton Dickinson lowered its annual profit forecast below Wall Street expectations, after the sale of its bioscience and diagnostics unit to ...

FRANKLIN LAKES, N.J., Nov. 13, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Duncan Regional Hospital ("DRH ...

BD Alaris™ EMR Interoperability enables seamless connection of infusion pumps into MEDITECH's Patient Care and Patient Safety solution BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global ...

Alaris’ investment consists of C$85m of preferred equity and C$30.5m of common equity Optimus was founded in 2010 Alaris Equity Partners has made a C$115.5 million ($82.1 million) investment in ...

It's hard out here for some shrimp. Several brands of shellfish were recalled by the U.S. Food & Drug Administration in September. A brand of frozen burrito bowls was also recalled for undeclared ...

FRANKLIN LAKES, N.J. (Sept. 12, 2025) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today expanded their Class I voluntary recall initiated in the ...

BD (NYSE: BDX) + is dealing with another recall related to its Alaris infusion pump system. Our sister site, Drug Delivery Business News, reports that the medtech giant announced a voluntary recall ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued a voluntary recall related to certain Alaris™ and BD Alaris™ Pump Modules that may have been ...

Becton, Dickinson and Company’s BDX, or popularly known as BD, initiated the recall of its infusion pumps last month after customer reports indicated software issues, potentially leading to inaccurate ...